Abstract
FOR the first time, prostate-specific antigen (PSA)-based prostate cancer screening has been included in the Screening Recommendations published by the European Commission (EC). A series of presentations and discussions were held at the European Association of Urology (EAU) 2023 Congress in Milan, Italy, on how European Union (EU) member states should swiftly implement these recommendations in their own populations. Emphasis was placed on raising awareness and promoting risk stratification before biopsy to reduce overdiagnosis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
